Cogent Biosciences, INC. (COGT) — SC 13D/A Filings
All SC 13D/A filings from Cogent Biosciences, INC.. Browse 4 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (4)
-
Fairmount Funds Boosts Cogent Biosciences Stake to 11.4%
— Jun 13, 2024 Risk: medium
Fairmount Funds Management LLC, through its affiliate Fairmount Healthcare Fund II GP LLC, has amended its Schedule 13D filing regarding Cogent Biosciences, Inc -
Fairmount Funds Amends Cogent Biosciences Stake
— Apr 1, 2024 Risk: medium
Fairmount Funds Management LLC, through its affiliates Fairmount Healthcare Fund GP LLC and Fairmount Healthcare Fund II GP LLC, has amended its Schedule 13D fi -
Fairmount Funds Amends Cogent Biosciences Stake
— Mar 27, 2024 Risk: medium
Fairmount Funds Management LLC, through its group members Fairmount Healthcare Fund GP LLC and Fairmount Healthcare Fund II GP LLC, has amended its Schedule 13D -
Fairmount Funds Amends Cogent Biosciences Stake
— Feb 16, 2024 Risk: low
Fairmount Funds Management LLC, along with Fairmount Healthcare Fund GP LLC and Fairmount Healthcare Fund II GP LLC, filed an Amendment No. 3 to Schedule 13D on
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX